受强制性开放获取政策约束的文章 - Michael Heinrich了解详情
无法在其他位置公开访问的文章：13 篇
Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases
LR Klug, JD Kent, MC Heinrich
Pharmacology & therapeutics 191, 123-134, 2018
强制性开放获取政策： US Department of Veterans Affairs
Genotyping and immunohistochemistry of gastrointestinal stromal tumors: an update
BP Rubin, MC Heinrich
Seminars in Diagnostic Pathology 32 (5), 392-399, 2015
强制性开放获取政策： US Department of Veterans Affairs, V Foundation, USA
Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors
AE Bannon, LR Klug, CL Corless, MC Heinrich
Expert review of molecular diagnostics 17 (5), 445-457, 2017
强制性开放获取政策： US Department of Veterans Affairs
KIT-dependent and KIT-independent genomic heterogeneity of resistance in gastrointestinal stromal tumors—TORC1/2 inhibition as salvage strategy
T Mühlenberg, J Ketzer, MC Heinrich, S Grunewald, A Marino-Enriquez, ...
Molecular cancer therapeutics 18 (11), 1985-1996, 2019
强制性开放获取政策： US Department of Veterans Affairs
Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases
G Kang, Y Kang, KH Kim, SY Ha, JY Kim, YM Shim, MC Heinrich, KM Kim, ...
Histopathology 71 (5), 805-812, 2017
强制性开放获取政策： US Department of Veterans Affairs
Treatment options for metastatic gastrointestinal stromal tumors to the liver: a review
HA Lillemoe, KW Brudvik, JN Vauthey
Seminars in liver disease 39 (03), 395-402, 2019
强制性开放获取政策： US National Institutes of Health
Defining the impact of adjuvant therapy in molecularly defined subsets of gastrointestinal stromal tumor: from lumping to splitting
MC Heinrich, CL Corless, GD Demetri
JAMA oncology 3 (5), 597-599, 2017
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs, V …
Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors
C Serrano, S Rothschild, G Villacampa, MC Heinrich, S George, JY Blay, ...
Nature medicine 29 (11), 2689-2692, 2023
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs
Disease-free interval is associated with oncologic outcomes in patients with recurrent gastrointestinal stromal tumor
TL Sutton, BS Walker, KG Billingsley, BC Sheppard, CL Corless, ...
Annals of surgical oncology 28, 7912-7920, 2021
强制性开放获取政策： US Department of Veterans Affairs
Potassium Carbonate Promoted C–N Coupling Reaction between Benzamides and Aryl Iodides
F Huang, S Wu, W Hu, S Zhang
Synthesis 50 (05), 1090-1096, 2018
强制性开放获取政策： 国家自然科学基金委员会
Case series of chronic myeloid leukemia patients who maintained deep molecular response (DMR) with very low-dose ponatinib: Experience in discontinuing low-dose ponatinib and …
J Cohen, A Palumbo, J Wing, MC Heinrich
Leukemia & Lymphoma 61 (10), 2511-2514, 2020
强制性开放获取政策： US Department of Veterans Affairs
Treatment of chronic myeloid leukemia with BCR-ABL kinase inhibitors
MJ Mauro, MC Heinrich
Innovative Leukemia and Lymphoma Therapy, 411-428, 2019
强制性开放获取政策： US Department of Veterans Affairs
Regorafenib for treatment of imatinib-and sunitinib-resistant metastatic gastrointestinal stromal tumors
MM Daughety, MC Heinrich
Expert Opinion on Orphan Drugs 4 (6), 659-670, 2016
强制性开放获取政策： US Department of Veterans Affairs
可在其他位置公开访问的文章：102 篇
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor
MC Heinrich, RG Maki, CL Corless, CR Antonescu, A Harlow, D Griffith, ...
Journal of clinical oncology 26 (33), 5352-5359, 2008
强制性开放获取政策： US National Institutes of Health
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal …
MC Heinrich, K Owzar, CL Corless, D Hollis, EC Borden, CDM Fletcher, ...
Journal of clinical oncology 26 (33), 5360-5367, 2008
强制性开放获取政策： US National Institutes of Health
Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
FS Hodi, CL Corless, A Giobbie-Hurder, JA Fletcher, M Zhu, ...
Journal of clinical oncology 31 (26), 3182-3190, 2013
强制性开放获取政策： US National Institutes of Health
Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors
J Chmielecki, AM Crago, M Rosenberg, R O'Connor, SR Walker, ...
Nature genetics 45 (2), 131-132, 2013
强制性开放获取政策： US National Institutes of Health
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of …
BL Eisenberg, J Harris, CD Blanke, GD Demetri, MC Heinrich, JC Watson, ...
Journal of surgical oncology 99 (1), 42-47, 2009
强制性开放获取政策： US National Institutes of Health
Heterogeneity of kinase inhibitor resistance mechanisms in GIST
B Liegl, I Kepten, C Le, M Zhu, GD Demetri, MC Heinrich, CDM Fletcher, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008
强制性开放获取政策： US National Institutes of Health, Austrian Science Fund
Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failure
TP Hughes, MJ Mauro, JE Cortes, H Minami, D Rea, DJ DeAngelo, ...
New England Journal of Medicine 381 (24), 2315-2326, 2019
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs
出版信息和资助信息由计算机程序自动确定